Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Dual-task gait training vs repetitive task training after stroke

Official title: Comparative Effects of Dual-task Gait Training and Repetitive Task Training on Dynamic Balance, Walking Function, Muscle Strength and Risk of Fall in Chronic Stroke

Run by Riphah International University · NCT07726017 · Data updated 2026-11-12

This study tests whether dual-task gait training or repetitive task training helps improve walking, balance, and strength for people who are more than 6 months post-stroke.

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment82 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Sialkot)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJuly 30, 2026
Study endsAugust 2, 2026
Registry record updatedJuly 24, 2026
Trial IDNCT07726017 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–70 with ischemic or hemorrhagic stroke 6–12 months prior, who have balance or gait impairments and are ambulatory with or without aid.

Probably not a fit

Individuals with recurrent strokes, other neurological or major medical conditions, or severe cognitive or communication impairments may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-blinded randomized trial compares two rehabilitation approaches for chronic stroke survivors aged 40–70. Participants are assigned to either dual-task gait training or repetitive task training for 8 weeks, three sessions per week. Outcomes include walking function, balance confidence, fall risk, and muscle strength, measured with standard tests. Non-probability convenience sampling will recruit 82 participants from diverse community areas in Gujrat, with statistical analysis planned in SPSS v25. Results will inform which training approach more effectively improves gait and functional mobility after stroke.

Why it matters

Potential benefit: If successful, the preferred training could lead to better walking ability and reduced fall risk for chronic stroke patients.

How similar studies have gone: Previous research in post-stroke rehabilitation supports benefits from task-specific gait training and multitask approaches, though direct comparison is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient is between the age of 40 to 70 Male and female patients. Chronic post-stroke patients who experienced either ischemic or hemorrhagic stroke between 6 months to 1 year.

Participants who have issues in balance control and walking with berg balance score \< 22 that indicates need for walking assistance and are at fall risk.

Participants who reported at least one fall in the past 6 months but retain ambulatory ability with/without aid.

Exclusion Criteria:

* Recurrent stroke patients. Participants included in other training/study. other neurological conditions, cardiovascular condition, other serious diseases or conditions (e.g., osteoporosis) Patient with severe hypertension, congestive heart failure, unstable cardiac status, aphasia, or cognitive disabilities for which exercise is not recommended.

Patients whose walking abilities are impacted by various medical conditions and neurologic illnesses that are worsening.

Where it's running

  • Amin Welfare & Teaching Hospital
    Sialkot, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.